Salazar Discloses SpaceX and Berkshire Trades
Rep. Salazar disclosed purchases in SpaceX and Berkshire Hathaway, alongside a same-day Moderna trade coinciding with a Phase 3 vaccine announcement.
Representative Maria Elvira Salazar disclosed recent stock transactions that include positions in companies led by Elon Musk and Warren Buffett. According to reports from GN stocks/nasdaq, the Florida Republican bought shares of Space Exploration Technologies Corp and Berkshire Hathaway in early August. These purchases were accompanied by sales of IBM and Qualcomm, marking a shift in her portfolio composition during the quarter.
The disclosure highlights specific timing relative to market events. Salazar bought SpaceX stock on August 12, when shares traded between $134.01 and $149.60. She also acquired Berkshire Hathaway Class B shares on August 7, following earlier purchases in July. These moves distinguish her trading activity from other congressional members who may have engaged with these assets at different valuation points.
SpaceX and Berkshire Purchases
Salazar reported buying $1,000 to $15,000 worth of SpaceX stock on two separate occasions on August 12. This investment aligns with the company's status as a public entity trading near $148.18. The purchase suggests a confidence in the company's leadership and its long-term objectives regarding lunar and Martian exploration, tying the financial bet directly to the CEO's strategic vision.
Simultaneously, the representative bought $1,000 to $15,000 in Berkshire Hathaway shares on August 7. This follows earlier trades in July ranging from $1,000 to $50,000. Despite Warren Buffett stepping down as CEO at the end of 2025, the company's core holdings remain influential. Salazar’s continued accumulation indicates a bet on the enduring performance of the firm’s legacy portfolio under new CEO Greg Abel.
Moderna Trade Amidst Vaccine News
On August 19, Salazar disclosed both the purchase and sale of Moderna Inc shares on the same day. This activity coincided with the company announcing a successful Phase 3 trial for a melanoma vaccine that utilizes Merck & Co’s Keytruda. Moderna’s stock was highly volatile during this period, trading in a wide range from $114.46 to $176.66.
The representative also bought Merck shares on August 19, which remain unsold. The simultaneous engagement with both biotech firms reflects a strategic interest in their collaborative oncology efforts. While the Moderna position was closed out immediately, the retention of Merck shares signals a longer-term hold on the pharmaceutical company following the regulatory milestone.
Historical Trading Volume Context
Data from Quiver Quantitative indicates that Salazar has executed over 120 trades since 2022, totaling $8.67 million. After a period of inactivity in 2025, her trading volume has increased significantly in 2026. She has already recorded over $1.55 million in transactions this year, comprising $1.33 million in purchases and $218,000 in sales.
Salazar serves on the House Committee on Foreign Affairs and the Financial Services Committee, including subcommittees for housing, capital markets, and national security. These assignments place her financial decisions under heightened scrutiny by retail investors who monitor congressional trading for potential market signals or conflicts of interest.
